Eagle Asset Management Inc Novavax Inc Transaction History

Eagle Asset Management Inc

  • $18.1 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 11, 2021
SELL
$121.0 - $257.67 $16.9 Million - $35.9 Million
-139,518 Closed
0 $0
Q1 2021

May 14, 2021
BUY
$112.98 - $319.93 $1.92 Million - $5.45 Million
17,020 Added 13.89%
139,518 $25.9 Million
Q4 2020

Feb 12, 2021
SELL
$78.74 - $139.5 $720,707 - $1.28 Million
-9,153 Reduced 6.95%
122,498 $13.7 Million
Q3 2020

Nov 12, 2020
BUY
$79.44 - $178.51 $10.5 Million - $23.5 Million
131,651 New
131,651 $14.2 Million

Others Institutions Holding NVAX

# of Institutions
286
Shares Held
84.8M
Call Options Held
5.43M
Put Options Held
9M
View Full List

About NOVAVAX INC

NVAX Quotes by TradingView
  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $713M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Eagle Asset Management Inc Portfolio

Follow Eagle Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email